These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26413217)

  • 1. A novel DNA damage response mediated by DNA mismatch repair in Caenorhabditis elegans: induction of programmed autophagic cell death in non-dividing cells.
    Moriwaki T; Kato Y; Nakamura C; Ishikawa S; Zhang-Akiyama QM
    Genes Cancer; 2015 Jul; 6(7-8):341-55. PubMed ID: 26413217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational signatures of DNA mismatch repair deficiency in
    Meier B; Volkova NV; Hong Y; Schofield P; Campbell PJ; Gerstung M; Gartner A
    Genome Res; 2018 May; 28(5):666-675. PubMed ID: 29636374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines.
    Hassen S; Ali AA; Kilaparty SP; Al-Anbaky QA; Majeed W; Boman BM; Fields JZ; Ali N
    Mol Cell Biochem; 2016 Jan; 412(1-2):297-305. PubMed ID: 26728996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation rates, spectra and hotspots in mismatch repair-deficient Caenorhabditis elegans.
    Denver DR; Feinberg S; Estes S; Thomas WK; Lynch M
    Genetics; 2005 May; 170(1):107-13. PubMed ID: 15716493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity (review).
    Fedier A; Fink D
    Int J Oncol; 2004 Apr; 24(4):1039-47. PubMed ID: 15010846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM Induces Cell Death with Autophagy in Response to H
    Moriwaki T; Yamasaki A; Zhang-Akiyama QM
    Oxid Med Cell Longev; 2018; 2018():3862070. PubMed ID: 30057676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATR-Chk1 activation mitigates replication stress caused by mismatch repair-dependent processing of DNA damage.
    Gupta D; Lin B; Cowan A; Heinen CD
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1523-1528. PubMed ID: 29378956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel role for DNA mismatch repair and the autophagic processing of chemotherapy drugs in human tumor cells.
    Zeng X; Kinsella TJ
    Autophagy; 2007; 3(4):368-70. PubMed ID: 17426439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular resistance and hypermutability in mismatch repair-deficient human cancer cell lines following treatment with methyl methanesulfonate.
    Glaab WE; Risinger JI; Umar A; Barrett JC; Kunkel TA; Tindall KR
    Mutat Res; 1998 Feb; 398(1-2):197-207. PubMed ID: 9626980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells.
    Zeng X; Yan T; Schupp JE; Seo Y; Kinsella TJ
    Clin Cancer Res; 2007 Feb; 13(4):1315-21. PubMed ID: 17317843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling cell cycle arrest and cell death through the MMR System.
    O'Brien V; Brown R
    Carcinogenesis; 2006 Apr; 27(4):682-92. PubMed ID: 16332722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines.
    Chang DK; Goel A; Ricciardiello L; Lee DH; Chang CL; Carethers JM; Boland CR
    Cancer Lett; 2003 Jun; 195(2):243-51. PubMed ID: 12767533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes.
    Durant ST; Morris MM; Illand M; McKay HJ; McCormick C; Hirst GL; Borts RH; Brown R
    Curr Biol; 1999 Jan; 9(1):51-4. PubMed ID: 9889125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
    Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
    Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase.
    Stojic L; Mojas N; Cejka P; Di Pietro M; Ferrari S; Marra G; Jiricny J
    Genes Dev; 2004 Jun; 18(11):1331-44. PubMed ID: 15175264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance.
    Gibson SL; Narayanan L; Hegan DC; Buermeyer AB; Liskay RM; Glazer PM
    Cancer Lett; 2006 Dec; 244(2):195-202. PubMed ID: 16426742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch repair proteins as sensors of alkylation DNA damage.
    Wang JY; Edelmann W
    Cancer Cell; 2006 Jun; 9(6):417-8. PubMed ID: 16766259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia effects on Hsp27 and Hsp72 associations with mismatch repair (MMR) proteins and cisplatin toxicity in MMR-deficient/proficient colon cancer cell lines.
    Sottile ML; Losinno AD; Fanelli MA; Cuello-Carrión FD; Montt-Guevara MM; Vargas-Roig LM; Nadin SB
    Int J Hyperthermia; 2015; 31(5):464-75. PubMed ID: 26043026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.